TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
3/29/21 16:05 | 3/25/21 | IDRA | Idera Pharmaceuticals, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Kirby John J. | PA | O | CFO | S | -9 | 1.42 | 0 | -6 | -18 | 28 | D | ||||||||||||||
1/12/21 19:12 | 1/12/21 | IDRA | Idera Pharmaceuticals, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Kirby John J. | PA | O | CFO | S.d | -7 | 4.22 | 0 | -2 | -5 | 34 | D | ||||||||||||||
1/6/21 17:04 | 1/5/21 | IDRA | Idera Pharmaceuticals, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Kirby John J. | PA | O | CFO | S | -3 | 3.90 | 0 | -1 | -2 | 36 | D | ||||||||||||||
1/14/20 18:07 | 1/7/20 | IDRA | Idera Pharmaceuticals, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Kirby John J. | PA | O | CFO | S.a | -2 | 1.78 | 0 | -1 | -5 | 16 | D | ||||||||||||||
1/10/20 08:11 | 1/7/20 | IDRA | Idera Pharmaceuticals, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Kirby John J. | PA | O | CFO | S | -2 | 1.78 | 0 | -1 | -5 | 16 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |